Our findings showed that Nrf2 plays an oncogenic role in the formation of liver cancer since the HCC group had elevated Nrf2 levels, which were reversed to normal levels in the groups receiving CANA treatment. This evidence concerns the gene NFE2L2 and hepatocellular carcinoma.